Method. The study was designed as retrospective, and vimentin, Ki67, and CD44 expressions were evaluated by immunohistochemistry in 53 pancreatic ductal adenocarcinoma cases. The gene discussed is MKI67; the disease is pancreatic ductal adenocarcinoma.